NewsCase
.com
Financial Intelligence
Market Analysis
Defense & Aerospace
AI & Tech
Banking & Finance
Crypto
European Stocks
Menu
Market Analysis
Defense & Aerospace
AI & Tech
Banking & Finance
Crypto
European Stocks
Search NewsCase
Viking Therapeutics
Viking Therapeutics Emerges as Prime Acquisition Candidate in Obesity Drug Race
kashif hafeez
-
December 16, 2025
Institutional Investors Pile Into Viking Therapeutics Stock
angelina
-
December 13, 2025
Viking Therapeutics Gains Momentum as Key Clinical and Financial Catalysts Align
angelina
-
December 12, 2025
Institutional Investors Signal Confidence in Viking Therapeutics’ Weight-Loss Ambitions
angelina
-
December 12, 2025
Viking Therapeutics Stock Finds Its Footing After Recent Swings
Brett Shapiro
-
December 11, 2025
Major Investor Boosts Stake in Viking Therapeutics Amid Insider Sales
Brett Shapiro
-
December 6, 2025
Viking Therapeutics Emerges as a Potential Acquisition Target in Booming Obesity Market
angelina
-
December 4, 2025
Viking Therapeutics Gains Momentum with Accelerated Clinical Trial
angelina
-
December 3, 2025
Major Investor Exit Sparks Volatility for Viking Therapeutics Shares
Brett Shapiro
-
December 2, 2025
Viking Therapeutics: A Brewing Storm of Bullish Bets and Bearish Pressure
kashif hafeez
-
November 28, 2025
Viking Therapeutics Accelerates Toward Obesity Treatment Approval
November 24, 2025
Viking Therapeutics Gains Momentum with Accelerated Trial Enrollment
angelina
-
November 20, 2025
Viking Therapeutics Stock Surges on Clinical Trial Milestone
Brett Shapiro
-
November 20, 2025
Viking Therapeutics Achieves Key Enrollment Milestone in Obesity Drug Trial
Brett Shapiro
-
November 19, 2025
Viking Therapeutics Hits Major Enrollment Target for Obesity Drug Trial
November 19, 2025
1
2
Page 1 of 2